04.07.2019 • NewsElaine BurridgeGelest

Gelest Boosts Portfolio with Bimax Buy

Gelest Boosts Portfolio with Bimax Buy
Gelest Boosts Portfolio with Bimax Buy

Gelest, a US manufacturer of silicones, organosilanes and metal-organics, has purchased Bimax, a producer of specialty monomers and polymers used to make contact and intraocular lenses, personal care products, coatings and adhesives, among other advanced technology applications. Financial terms of the deal were not disclosed.

Commenting on the acquisition, Ken Gayer, Gelest’s CEO, said:  “Bimax strengthens our position in high-growth value-added applications, provides access to new customers and talent and expands our production capability and R&D pipeline.”

Andre Moura, managing director at Gelest’s majority shareholder New Mountain Capital, added that the two businesses were highly complementary.

Gelest has been a portfolio company of New York-based investment firm New Mountain Capital since March 2017. New Mountain Capital owns a controlling interest in the Morrisville, Pennsylvania-based company, with Gelest’s founder and management team maintaining a “significant” shareholding.

Bimax, which is headquartered in Glen Rock, Pennsylvania, will continue to operate under its own name and will retain all its employees in their current roles.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.